Your browser doesn't support javascript.
loading
In vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell "kick" and "kill" in strategy for virus eradication.
Marsden, Matthew D; Loy, Brian A; Wu, Xiaomeng; Ramirez, Christina M; Schrier, Adam J; Murray, Danielle; Shimizu, Akira; Ryckbosch, Steven M; Near, Katherine E; Chun, Tae-Wook; Wender, Paul A; Zack, Jerome A.
Afiliación
  • Marsden MD; Department of Medicine, Division of Hematology and Oncology, University of California Los Angeles, Los Angeles, California, United States of America.
  • Loy BA; Department of Chemistry and Department of Chemical and Systems Biology, Stanford University, Stanford, California, United States of America.
  • Wu X; Department of Microbiology, Immunology, and Molecular Genetics, University of California Los Angeles, Los Angeles, California, United States of America.
  • Ramirez CM; Department of Biostatistics, School of Public Health, University of California Los Angeles, Los Angeles, California, United States of America.
  • Schrier AJ; Department of Chemistry and Department of Chemical and Systems Biology, Stanford University, Stanford, California, United States of America.
  • Murray D; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Shimizu A; Department of Chemistry and Department of Chemical and Systems Biology, Stanford University, Stanford, California, United States of America.
  • Ryckbosch SM; Department of Chemistry and Department of Chemical and Systems Biology, Stanford University, Stanford, California, United States of America.
  • Near KE; Department of Chemistry and Department of Chemical and Systems Biology, Stanford University, Stanford, California, United States of America.
  • Chun TW; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Wender PA; Department of Chemistry and Department of Chemical and Systems Biology, Stanford University, Stanford, California, United States of America.
  • Zack JA; Department of Medicine, Division of Hematology and Oncology, University of California Los Angeles, Los Angeles, California, United States of America.
PLoS Pathog ; 13(9): e1006575, 2017 Sep.
Article en En | MEDLINE | ID: mdl-28934369
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T CD4-Positivos / VIH-1 / Latencia del Virus / Fármacos Anti-VIH / Brioestatinas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: PLoS Pathog Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T CD4-Positivos / VIH-1 / Latencia del Virus / Fármacos Anti-VIH / Brioestatinas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: PLoS Pathog Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos